Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gloryvee Rivera
Institution:
Frederick National Laboratory for Cancer Research
Observed institutions:
Frederick National Laboratory for Cancer Research,
Leidos Biomedical Research Inc. (United States),
Catholic University of America
ORCID:
0000-0003-1683-4598
Observed ORCID:
0000-0003-1683-4598
OpenAlex ID:
A5038405039
Surface modification of magnetic nanoparticles with oleylamine and gum Arabic
2007
·
Otto C. Wilson
, Erin Blair
, et al.
·
Materials Science and Engineering C
·
33
Abstract 5056: Quality control efforts in a large-scale, preclinical trial of rare cancer PDXs by the National Cancer Institute's patient-derived models repository (NCI PDMR)
2020
·
Yvonne A. Evrard
, Biswajit Das
, et al.
·
Cancer Research
·
2
Abstract 40: NCI patient derived models repository: PDX, organoid and cell lines from the same patient - bridging the translational pipeline
2023
·
Yvonne A. Evrard
, Li Chen
, et al.
·
Cancer Research
·
1
Abstract 3916: Patient-derived organoid and cell culture models from the NCI Patient-Derived Models Repository (NCI PDMR) preserve genomic stability and heterogeneity of patient tumor specimens
2020
·
Biswajit Das
, Yvonne A. Evrard
, et al.
·
Cancer Research
·
1
Abstract 6072: Chromosomal aneuploidy, whole-genome doubling and mutational signatures in NCI PDMR models
2023
·
Li Chen
, Biswajit Das
, et al.
·
Cancer Research
Abstract 2050: Molecular subclassification of NCI PDMR breast cancer models using PAM50 gene expression signature
2023
·
Peter I. Wu
, Lindsay Dutko
, et al.
·
Cancer Research
Abstract 36: Comparing twenty-two matched patient-derived cell lines developed from either patient, PDX, or organoid tumor cell material
2023
·
Cindy R. Timme
, Ting-Chia Chang
, et al.
·
Cancer Research
Abstract 80: Genomic characterization of PDX models from rare cancer patients in the NCI Patient-Derived Models Repository
2022
·
Li Chen
, Rini Pauly
, et al.
·
Cancer Research
Abstract 1913: Quality control workflows developed for the NCI Patient-Derived Models Repository using low pass whole genome sequencing and whole exome sequencing
2022
·
Ting-Chia Chang
, Li Chen
, et al.
·
Cancer Research
Abstract 3015: Applications of immunohistochemistry in characterization of patient derived xenograft models
2021
·
Lindsay Dutko
, Gloryvee Rivera
, et al.
·
Cancer Research
Abstract 3010: Single agent response comparisons in a large-scale, preclinical trial of rare cancer PDXs by the National Cancer Institute's patient-derived models repository
2021
·
Yvonne A. Evrard
, Sergio Y. Alcoser
, et al.
·
Cancer Research
Abstract 3554: Genomic landscape of acquired uniparental disomy in NCI PDMR patient derived xenograft models
2020
·
Rajesh Patidar
, Li Chen
, et al.
·
Cancer Research
Abstract 1056: Xenograft-associated B cell lymphoproliferative disease (XABLD) as a surrogate model to study Epstein-Barr virus (EBV) driven B cell Diseases
2019
·
Tomas Vilimas
, Gloryvee Rivera
, et al.
·
Cancer Research
Abstract 1056: Xenograft-associated B cell lymphoproliferative disease (XABLD) as a surrogate model to study Epstein-Barr virus (EBV) driven B cell Diseases
2019
·
Tomas Vilimas
, Gloryvee Rivera
, et al.
·
Tumor Biology
Abstract 1038: Xenograft-associated B cell lymphoproliferative disease as a surrogate model to study Epstein-Barr virus (EBV) driven lymphoma of the elderly
2018
·
Tomas Vilimas
, Gloryvee Rivera
, et al.
·
Cancer Research
Assessment of the genomic stability and molecular landscape of patient-derived xenograft (PDX) models from NCI’s Patient-Derived Models Repository (PDMR).
2018
·
Bishwajit Das
, Yvonne A Evrard
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
17
Citation count:
37
H-index:
2
I10-index:
1
Year
Topic
Type